Efficacy and Safety of Telbivudine in Treatment naïve Patients With Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB)
Clinical trial NCT00412750 · TERMINATED
Trial details
- NCT number
- NCT00412750
- Sponsor
- Novartis
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2009-02-01
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.